C. Eric Winzer is Director at Nuo Therapeutics, Inc. (AURX). They have made 1 open-market trade across 1 company since 2016, most recently 2026-06-30.
CIK 0001205362
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $25K since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AURX | 173,050 | — |
| PrivateUnlisted | 25,000 | — |
| Total | $0 |
Shares reported on the most recent Form 4, priced at the 2026-07-02 close. 2 holdings could not be priced and are excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PrivateNuo Therapeutics, Inc. | BUY | 2016-05-05 | 2016-07-29 | $1.00 | $25K | N/A | N/A | N/A |